Home › Osteosarcoma › California › Los Angeles
Osteosarcoma clinical trials in Los Angeles, CA
7 studies for Osteosarcoma are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
RecruitingPhase 2
- Children's Hospital Los Angeles, Los Angeles
Losartan + Sunitinib in Treatment of Osteosarcoma
RecruitingPhase 1
- Children's Hospital Los Angeles, Los Angeles
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RecruitingPhase 3
- Children's Hospital Los Angeles, Los Angeles
- Kaiser Permanente Los Angeles Medical Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Children's Hospital Los Angeles, Los Angeles
An Organoid-based Functional Precision Medicine Trial in Osteosarcoma
RecruitingObservational study
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
RecruitingPhase 1/2
- UCLA, Los Angeles
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Recruiting
- Oncology Institute for Hope and Innovation, Los Angeles
Osteosarcoma trials in other cities
- Memphis, TN10 studies
- Atlanta, GA10 studies
- St. Louis, MO10 studies
- Boston, MA9 studies
- Mountain View, CA8 studies
- Chicago, IL7 studies
- Birmingham, AL7 studies
- Houston, TX7 studies
- Tampa, FL6 studies
- Cincinnati, OH6 studies
- New York City, NY6 studies
- Philadelphia, PA6 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)73 studies
- Breast Cancer72 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.